The global tube feeding formula market size is expected to reach a valuation of US$ 5,245.8 million by the end of 2023. It is projected to expand at a decent CAGR of 6.9% for the forecast period 2023 to 2033. The market is anticipated to contribute a valuation of US$ 10,211.7 million in 2033.
Tube feeding is set to be a superior medical intervention that provides nutrition to individuals who are unable to eat orally. It involves the insertion of a feeding tube through the nose or mouth and into the digestive system.
It allows the delivery of liquid nutrition directly into the stomach or small intestine. Its high convenience is projected to make it one of the ideal feeding options for babies and aging populations.
A few feeding devices can be used to remove air from the intestines. Suction attached to the tubes can remove gas, thereby decreasing distention (enlargement) and bloating.
The tube feeding formula industry is primarily driven by rising prevalence of chronic disorders such as metabolic syndrome across the globe. Increasing patient care expenditure and surging demand from the geriatric population are a couple of other key factors pushing demand.
According to the International Diabetes Federation (IDF), in 2021, around 537 million adults were living with diabetes worldwide. The number is expected to reach 643 million by 2030 and 783 million by the end of 2045. Such rise in terms of metabolic diseases is expected to push the market ahead during the forecast period.
High prevalence of cancer, gastrointestinal diseases, and neurological disorders is also expected to propel tube feeding formula demand. These are required to provide adequate nutrition and hydration to patients.
As per the World Health Organization (WHO), in 2020, cancer resulted in about 10 million deaths across the globe. Around 30% of cancer cases in low- and lower-middle-income countries are attributed to infections that cause cancer such as hepatitis and human papillomavirus (HPV).
The Pan American Health Organization (PAHO), on the other hand, mentions that in 2019, digestive disorders caused a mortality rate of 28.4 deaths per 100,000 people in the Region of the Americas. It resulted in the deaths of 215,168 men and 160,002 women from such disorders. The statistics prove that prevalence of these disorders are likely to surge by 2033, thereby augmenting tube feeding formula sales.
| Attributes | Key Insights |
|---|---|
| Tube Feeding Formula Market Estimated Size (2023E) | US$ 5,245.8 million |
| Projected Market Valuation (2033F) | US$ 10,211.7 million |
| Value-based CAGR (2023 to 2033) | 6.9% |
| Collective Value Share: Top 3 Countries | US$ 4177.8 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to Future Market Insights (FMI), the global tube feeding formula industry grew at a moderate CAGR of 5.3% from 2018 to 2022. The coronavirus pandemic had propelled the global market to a certain extent in the historical period.
Back in 2020, when the pandemic had hit the globe, there was a surging rate of hospitalization, with numerous patients requiring intensive care and support. It led to an increased need for tube feeding formulas to provide adequate nutrition for patients who were unable to eat.
The pandemic had also led to quarantine measures that had made it difficult for caregivers and family members to provide support to patients who required feeding assistance. Tube feeding formulas were considered to be a convenient way to ensure that patients received the nutrition they need while minimizing the risk of exposure to the virus.
Awareness of various benefits of enteral feeding among healthcare providers and patients is set to increase through 2033. It is anticipated to lead to more frequent use of this method of nutritional support.
In a few cases, tube feeding formulas might be used in place of or in addition to parenteral nutrition, which involves administering nutrients through an IV. The market is hence projected to remain lucrative, exhibiting steady growth at 6.9% CAGR between 2023 and 2033.
| Market Statistics | Details |
|---|---|
| Jan to Jun (H1), 2021 (A) | 5.6% |
| Jan to Jun (H1),2022 Projected (P) | 7.3% |
| Jan to Jun (H1), 2023 Projected (P) | 6.9% |
| Jan to Jun (H1),2022 Outlook (O) | 6.3% |
| Jul to Dec (H2), 2022 Outlook (O) | 6.2% |
| Jul to Dec (H2), 2022 Projected (P) | 7.3% |
| Jul to Dec (H2), 2021 (A) | 6.6% |
| BPS Change: H1,2022 (O) to H1,2022 (P) | 30 |
| BPS Change: H1,2022 (O) to H1,2021 (A) | 66 |
| BPS Change: H2, 2022 (O) to H2, 2022 (A) | 136 |
| BPS Change: H2, 2022 (O) to H2, 2022 (P) | -30 |
Principal Consultant
| Region | North America |
|---|---|
| Country | United States |
| CAGR | 4.2% |
| BPS Analysis | -789 |
| Market Value (2033) | US$ 2,362.6 million |
| Region | Europe |
|---|---|
| Country | United Kingdom |
| CAGR | 5.5% |
| BPS Analysis | -64 |
| Market Value (2033) | US$ 371.0 million |
| Region | Asia Pacific |
|---|---|
| Country | China |
| CAGR | 8.8% |
| BPS Analysis | 877 |
| Market Value (2033) | US$ 832.6 million |
| Region | Asia Pacific |
|---|---|
| Country | India |
| CAGR | 7.8% |
| BPS Analysis | -556 |
| Market Value (2033) | US$ 979.6 million |
| Region | Asia Pacific |
|---|---|
| Country | Japan |
| CAGR | 4.4% |
| BPS Analysis | -867 |
| Market Value (2033) | US$ 413.6 million |
Rising Prevalence of Cancer in China to Boost Sales of Tube Feeding Formulas for Adults
In 2033, China is expected to generate around 60.6% of the global tube feeding formula market share. It is projected to top a valuation of US$ 832.6 million by 2033.
China holds an enormous promise in the industry as it has a large population base of patients. Rising prevalence of chronic disease is also set to offer lucrative growth opportunities for medical nutrition firms to record high revenues in the country.
For example, according to the International Network for Cancer Treatment and Research, incidence of cancer is rapidly increasing in developing regions such as Asia Pacific, especially in countries such as India and China.
It is projected to lead to a rising demand for medical nutrition products. Growing investments in the pharmaceutical formulation segment are likely to provide manufacturers and new players with broad opportunities to record high growth.
Emergence of Ready-to-drink Supplements to Accelerate Demand for Enteral Formulary Substitutes in the United States
According to Future Market Insights (FMI), the United States is expected to elevate at an average CAGR of 4.2% from 2023 to 2033. It is anticipated to reach a market valuation of US$ 2,362.6 million in 2033.
Introduction of ready-to-drink & ready-to-use nutritional supplements and improvements in tube quality are projected to drive the United States market. Growing emphasis on developing technologically advanced instruments in product portfolios is also anticipated to propel growth.
Investment in research & development of new medical and nutritional products is another significant factor pushing demand. Financing from various businesses in the nutrition industry is further expected to propel market expansion in the United States.
Surging Demand for Home Enteral Nutrition Formulas to Create New Opportunities in the United Kingdom
The United Kingdom tube feeding formula industry is projected to expand at considerable CAGR of 5.5% from 2023 to 2033. It is likely to hold a market share of 15.6% in 2033.
A shift in the tube feeding industry from hospital care to home enteral nutrition (HEN) is expected to be a prominent trend in the country. Rising costs of hospital stays are expected to necessitate movement of patients who need nutritional support for a long time to HEN. Each year in the United Kingdom, number of patients receiving HEN feeding is more than twice the number receiving feeds in hospitals.
Technological developments in artificial nutrition and associated equipment are further anticipated to bolster demand. Rapid shift from costly acute hospital care settings to a community-based approach would also push demand for HEN by 2033.
Importance of patient and caregiver education is amplified with the transition from hospital to community care. Home assistance services and educational materials, as well as effective distribution methods, are set to create opportunities for manufacturers in the United Kingdom.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Elemental Tube Feeding Formulas to Showcase Exponential Demand through 2033
Based on product type, the elemental formulas segment is expected to dominate the global market in the next ten years. The segment is set to reach a valuation of US$ 1,396.5 million in 2023.
It is predicted to witness a decent CAGR of 5.9% from 2023 to 2033. The segment is also expected to acquire 24.2% of the global market share by 2033, followed by specialized formulas. The latter is set to be valued at US$ 1,319.4 million in 2023.
Elemental formula is made up of pre-digested nutrients that are simpler to digest and absorb. It is hence considered to be an excellent option for patients with gastrointestinal issues.
It is especially essential for patients who cannot digest proteins or have malabsorption problems. It is hypoallergenic, meaning it includes a few allergens that makes it an excellent option for people with food allergies or intolerances.
Elemental formulas can be used as a full nutritional replacement or as an addition to a regular diet. These are specially designed to satisfy patients' specific nutritional needs. These are more effective than specialized formulas due to which their demand among today’s consumers has been increasing.
Powdered Fiber Supplement for Tube Feeding to Witness Astonishing Demand by 2033
Powdered tube feeding formula by form is anticipated to remain at the forefront throughout the estimated time frame. Powdered formulas have a longer shelf life, as compared to semi-solid and liquid forms.
They can be kept for a longer period of time without spoiling. Both healthcare professionals and patients are likely to benefit from powdered formulas.
These formulas have the advantage of ease of transportation as the powdered form is lightweight and compact. It takes up less space, making it a popular option for healthcare facilities.
Customization of powdered tube feeding formula is frequently easy to suit the needs of individual patients. Healthcare providers can modify the amount of water added to the powder to achieve the best consistency for each patient.
Feeding Tube Formula Brands to Focus on Offering Prescription-based Products to Ensure Safety
In terms of distribution channel, the prescription-based segment is expected to flourish at 6.7% CAGR from 2023 to 2033. It is estimated to surpass a valuation of US$ 9,720.0 million by 2033.
Prescription-based tube feeding formulas are typically suggested by healthcare professionals, and can only be obtained with a prescription. It guarantees that the patient is being monitored by a doctor and that the formula is being used correctly. These are frequently customized to meet the patient's particular nutritional requirements, which is not always possible with over-the-counter formulas.
Prescription-based tube feeding formulas are usually intended to be safer for patients with specific medical conditions or those who require more specialized care. These formulas are also made in Food & Drug Administration (FDA)-approved facilities.
These formulas are hence subject to stringent quality control measures. It guarantees that the formulas are safe, effective, and can satisfy nutritional needs of users.
Manufacturers of tube feeding formulas are increasing their consumer base by expanding to developing countries. To do this, they need a strong network with distributors and suppliers of their products.
It is being carried out mainly by leading manufacturers in the industry. Distribution is completely handled by the distributor with whom they are in a partnership.
They are entering into partnerships with a single distributor, which is responsible for distributing its products to all the regions. A few other companies are entering into collaborations with different distributors for several regions.
For instance,
| Attribute | Details |
|---|---|
| Estimated Market Size (2023) | US$ 5,245.8 million |
| Projected Market Valuation (2033) | US$ 10,211.7 million |
| Value-based CAGR (2023 to 2033) | 6.9% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | Value (US$ million) and Volume (MT) |
| Key Regions Covered | Europe; North America; South Asia; Latin America; Oceania; East Asia; and the Middle East & Africa |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Italy, Spain, BENELUX, Nordics, Poland, Hungary, Romania, Czech Republic, Russia, China, Japan, South Korea, Taiwan, India, Association of Southeast Asian Nations, Australia and New Zealand, Gulf Cooperation Council countries, Türkiye, Northern Africa, and South Africa, Israel |
| Key Market Segments Covered | Product Type, Form, Primary Condition (C), End User, Distribution Channel, and Regions |
| Key Companies Profiled | J Nutritional Medicinals; Medline Industries; Grifols S.A; Otsuka Pharmaceutical Factory Inc.; Nestle (Nestle Health Science); Danone; Meiji Holdings Co.; Reckitt Benckiser Group Plc; Fresenius Kabi; B. Braun; Victus; Abbot Laboratories; Fresenius SE & Co. KGaA; Medtrition Inc; Other Players |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The projected CAGR of the tube-feeding formula market by 2033 is 6.9%.
The projected market value by 2033 is US$ 10,211.7 million.
The market is estimated to secure a valuation of US$ 5,245.8 million in 2023.
The healthcare industry is the key consumer of the tube-feeding formula market.
Abbott, Nestle, and Fresenius Kabi are the three key players in the market.
1. Executive Summary | Tube Feeding Formula Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Wheel of Fortune
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition
3. Market Dynamics
3.1. Drivers
3.1.1. Supply Side Drivers
3.1.2. Demand Side drivers
3.1.3. Economic Side Drivers
3.2. Restraints
3.3. Opportunity
3.4. Market trends By Region
3.5. Forecast Factors - Relevance & Impact
3.6. Packaging & Labelling Regulations
3.7. Regulatory Landscape
4. Value Chain Analysis
4.1. Operating margins at each node of the supply chain
4.2. List of Active Market Participants
5. Global - Pricing Analysis
5.1. Price Point Assessment by Region
5.1.1. Manufacturer-Level Pricing
5.1.2. Distributor Level Pricing
5.2. Price Point Assessment By Product
5.3. Price Forecast till 2033
6. Global Market Size (in Value (US$ million) and Volume (MT) Analysis 2018 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Size in Value (US$ million) and Volume (MT) Analysis, 2018 to 2022
6.2. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis By Product Type, 2018 to 2022
7.3. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast By Product Type, 2023 to 2033
7.3.1. Standard Formulas
7.3.2. Elemental Formulas
7.3.3. Blenderized Formulas with Real Food Ingredients
7.3.4. Specialized Formulas
7.3.5. Peptide Formulas (Semi-Elemental Formulas)
7.4. Market Attractiveness Analysis By Product Type
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Form
8.1. Introduction / Key Findings
8.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis By Form, 2018 to 2022
8.3. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast By Form, 2023 to 2033
8.3.1. Semi Solid
8.3.2. Liquids
8.3.3. Powder
8.4. Market Attractiveness Analysis By Form
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Primary Condition (C)
9.1. Introduction / Key Findings
9.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis By Primary Condition (C), 2018 to 2022
9.3. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast By Primary Condition (C), 2023 to 2033
9.3.1. General Well-being
9.3.2. Condition Specific
9.4. Market Attractiveness Analysis By Primary Condition (C)
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis By End User, 2018 to 2022
10.3. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast By End User, 2023 to 2033
10.3.1. Adult
10.3.2. Geriatric
10.3.3. Pediatric
10.4. Market Attractiveness Analysis By End User
11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis By Distribution Channel, 2018 to 2022
11.3. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast By Distribution Channel, 2023 to 2033
11.3.1. Prescription-based
11.3.2. Over-the-counter
11.4. Market Attractiveness Analysis By Distribution Channel
12. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region
12.1. Introduction
12.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis By Region, 2018 to 2022
12.3. Current Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast By Region, 2023 to 2033
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East & Africa
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022
13.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. United States
13.3.1.2. Canada
13.3.2. By Product Type
13.3.3. By Form
13.3.4. By Primary Condition (C)
13.3.5. By End User
13.3.6. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product Type
13.4.3. By Form
13.4.4. By Primary Condition (C)
13.4.5. By End User
13.4.6. By Distribution Channel
13.5. Key Takeaways
14. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022
14.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Argentina
14.3.1.4. Rest of Latin America
14.3.2. By Product Type
14.3.3. By Form
14.3.4. By Primary Condition (C)
14.3.5. By End User
14.3.6. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product Type
14.4.3. By Form
14.4.4. By Primary Condition (C)
14.4.5. By End User
14.4.6. By Distribution Channel
14.5. Key Takeaways
15. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022
15.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. United Kingdom
15.3.1.3. France
15.3.1.4. Italy
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Nordic
15.3.1.8. Russia
15.3.1.9. Poland
15.3.1.10. Rest of Europe
15.3.2. By Product Type
15.3.3. By Form
15.3.4. By Primary Condition (C)
15.3.5. By End User
15.3.6. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product Type
15.4.3. By Form
15.4.4. By Primary Condition (C)
15.4.5. By End User
15.4.6. By Distribution Channel
15.5. Key Takeaways
16. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022
16.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product Type
16.3.3. By Form
16.3.4. By Primary Condition (C)
16.3.5. By End User
16.3.6. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product Type
16.4.3. By Form
16.4.4. By Primary Condition (C)
16.4.5. By End User
16.4.6. By Distribution Channel
16.5. Key Takeaways
17. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022
17.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Malaysia
17.3.1.4. Indonesia
17.3.1.5. Singapore
17.3.1.6. Vietnam
17.3.1.7. Philippines
17.3.1.8. Rest of South Asia
17.3.2. By Product Type
17.3.3. By Form
17.3.4. By Primary Condition (C)
17.3.5. By End User
17.3.6. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product Type
17.4.3. By Form
17.4.4. By Primary Condition (C)
17.4.5. By End User
17.4.6. By Distribution Channel
17.5. Key Takeaways
18. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022
18.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product Type
18.3.3. By Form
18.3.4. By Primary Condition (C)
18.3.5. By End User
18.3.6. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product Type
18.4.3. By Form
18.4.4. By Primary Condition (C)
18.4.5. By End User
18.4.6. By Distribution Channel
18.5. Key Takeaways
19. Middle East & Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2018 to 2022
19.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2023 to 2033
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Türkiye
19.3.1.3. Egypt
19.3.1.4. South Africa
19.3.1.5. Rest of Middle East & Africa
19.3.2. By Product Type
19.3.3. By Form
19.3.4. By Primary Condition (C)
19.3.5. By End User
19.3.6. By Distribution Channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product Type
19.4.3. By Form
19.4.4. By Primary Condition (C)
19.4.5. By End User
19.4.6. By Distribution Channel
19.5. Key Takeaways
20. Country-level Market Analysis, 2022
20.1. United States Market Analysis
20.1.1. By Product Type
20.1.2. By Form
20.1.3. By Primary Condition (C)
20.1.4. By End User
20.1.5. By Distribution Channel
20.2. Canada Market Analysis
20.2.1. By Product Type
20.2.2. By Form
20.2.3. By Primary Condition (C)
20.2.4. By End User
20.2.5. By Distribution Channel
20.3. Brazil Market Analysis
20.3.1. By Product Type
20.3.2. By Form
20.3.3. By Primary Condition (C)
20.3.4. By End User
20.3.5. By Distribution Channel
20.4. Mexico Market Analysis
20.4.1. By Product Type
20.4.2. By Form
20.4.3. By Primary Condition (C)
20.4.4. By End User
20.4.5. By Distribution Channel
20.5. Argentina Market Analysis
20.5.1. By Product Type
20.5.2. By Form
20.5.3. By Primary Condition (C)
20.5.4. By End User
20.5.5. By Distribution Channel
20.6. Germany Market Analysis
20.6.1. By Product Type
20.6.2. By Form
20.6.3. By Primary Condition (C)
20.6.4. By End User
20.6.5. By Distribution Channel
20.7. United Kingdom Market Analysis
20.7.1. By Product Type
20.7.2. By Form
20.7.3. By Primary Condition (C)
20.7.4. By End User
20.7.5. By Distribution Channel
20.8. France Market Analysis
20.8.1. By Product Type
20.8.2. By Form
20.8.3. By Primary Condition (C)
20.8.4. By End User
20.8.5. By Distribution Channel
20.9. Italy Market Analysis
20.9.1. By Product Type
20.9.2. By Form
20.9.3. By Primary Condition (C)
20.9.4. By End User
20.9.5. By Distribution Channel
20.10. Spain Market Analysis
20.10.1. By Product Type
20.10.2. By Form
20.10.3. By Primary Condition (C)
20.10.4. By End User
20.10.5. By Distribution Channel
20.11. Belgium Market Analysis
20.11.1. By Product Type
20.11.2. By Form
20.11.3. By Primary Condition (C)
20.11.4. By End User
20.11.5. By Distribution Channel
20.12. Netherlands Market Analysis
20.12.1. By Product Type
20.12.2. By Form
20.12.3. By Primary Condition (C)
20.12.4. By End User
20.12.5. By Distribution Channel
20.13. Nordic Market Analysis
20.13.1. By Product Type
20.13.2. By Form
20.13.3. By Primary Condition (C)
20.13.4. By End User
20.13.5. By Distribution Channel
20.14. Russia Market Analysis
20.14.1. By Product Type
20.14.2. By Form
20.14.3. By Primary Condition (C)
20.14.4. By End User
20.14.5. By Distribution Channel
20.15. Poland Market Analysis
20.15.1. By Product Type
20.15.2. By Form
20.15.3. By Primary Condition (C)
20.15.4. By End User
20.15.5. By Distribution Channel
20.16. China Market Analysis
20.16.1. By Product Type
20.16.2. By Form
20.16.3. By Primary Condition (C)
20.16.4. By End User
20.16.5. By Distribution Channel
20.17. Japan Market Analysis
20.17.1. By Product Type
20.17.2. By Form
20.17.3. By Primary Condition (C)
20.17.4. By End User
20.17.5. By Distribution Channel
20.18. South Korea Market Analysis
20.18.1. By Product Type
20.18.2. By Form
20.18.3. By Primary Condition (C)
20.18.4. By End User
20.18.5. By Distribution Channel
20.19. India Market Analysis
20.19.1. By Product Type
20.19.2. By Form
20.19.3. By Primary Condition (C)
20.19.4. By End User
20.19.5. By Distribution Channel
20.20. Thailand Market Analysis
20.20.1. By Product Type
20.20.2. By Form
20.20.3. By Primary Condition (C)
20.20.4. By End User
20.20.5. By Distribution Channel
20.21. Malaysia Market Analysis
20.21.1. By Product Type
20.21.2. By Form
20.21.3. By Primary Condition (C)
20.21.4. By End User
20.21.5. By Distribution Channel
20.22. Vietnam Market Analysis
20.22.1. By Product Type
20.22.2. By Form
20.22.3. By Primary Condition (C)
20.22.4. By End User
20.22.5. By Distribution Channel
20.23. Philippines Market Analysis
20.23.1. By Product Type
20.23.2. By Form
20.23.3. By Primary Condition (C)
20.23.4. By End User
20.23.5. By Distribution Channel
20.24. Indonesia Market Analysis
20.24.1. By Product Type
20.24.2. By Form
20.24.3. By Primary Condition (C)
20.24.4. By End User
20.24.5. By Distribution Channel
20.25. Singapore Market Analysis
20.25.1. By Product Type
20.25.2. By Form
20.25.3. By Primary Condition (C)
20.25.4. By End User
20.25.5. By Distribution Channel
20.26. Australia Market Analysis
20.26.1. By Product Type
20.26.2. By Form
20.26.3. By Primary Condition (C)
20.26.4. By End User
20.26.5. By Distribution Channel
20.27. New Zealand Market Analysis
20.27.1. By Product Type
20.27.2. By Form
20.27.3. By Primary Condition (C)
20.27.4. By End User
20.27.5. By Distribution Channel
20.28. GCC Countries Market Analysis
20.28.1. By Product Type
20.28.2. By Form
20.28.3. By Primary Condition (C)
20.28.4. By End User
20.28.5. By Distribution Channel
20.29. Türkiye Market Analysis
20.29.1. By Product Type
20.29.2. By Form
20.29.3. By Primary Condition (C)
20.29.4. By End User
20.29.5. By Distribution Channel
20.30. Egypt Market Analysis
20.30.1. By Product Type
20.30.2. By Form
20.30.3. By Primary Condition (C)
20.30.4. By End User
20.30.5. By Distribution Channel
20.31. South Africa Market Analysis
20.31.1. By Product Type
20.31.2. By Form
20.31.3. By Primary Condition (C)
20.31.4. By End User
20.31.5. By Distribution Channel
21. Market Structure Analysis
21.1. Global Competition - a Dashboard View
21.2. Industry Structure Analysis
21.2.1. % tier 1 market players
21.2.2. % tier 2 market players
21.2.3. % tier 3 market players
21.3. Global Market Company Share Analysis
21.3.1. For Tier 1 Market Players, 2023
21.3.2. Company Market Share Analysis of Top 5 Players, By Region
21.4. Key Participants Market Presence (Intensity Mapping) by Region
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Kate Farms
22.3.1.1. Product Portfolio
22.3.1.2. Product Claim
22.3.1.3. Revenue by Market Segments (Product /Channel /Region)
22.3.1.4. Sales Footprint
22.3.1.5. Strategy Overview
22.3.1.5.1. Marketing Strategy
22.3.1.5.2. Product Strategy
22.3.1.5.3. Channel Strategy
22.3.1.6. SWOT Analysis
22.3.2. Nutritional Medicinals
22.3.2.1. Product Portfolio
22.3.2.2. Product Claim
22.3.2.3. Revenue by Market Segments (Product /Channel /Region)
22.3.2.4. Sales Footprint
22.3.2.5. Strategy Overview
22.3.2.5.1. Marketing Strategy
22.3.2.5.2. Product Strategy
22.3.2.5.3. Channel Strategy
22.3.2.6. SWOT Analysis
22.3.3. Medline Industries
22.3.3.1. Product Portfolio
22.3.3.2. Product Claim
22.3.3.3. Revenue by Market Segments (Product /Channel /Region)
22.3.3.4. Sales Footprint
22.3.3.5. Strategy Overview
22.3.3.5.1. Marketing Strategy
22.3.3.5.2. Product Strategy
22.3.3.5.3. Channel Strategy
22.3.3.6. SWOT Analysis
22.3.4. Grifols S.A
22.3.4.1. Product Portfolio
22.3.4.2. Product Claim
22.3.4.3. Revenue by Market Segments (Product /Channel /Region)
22.3.4.4. Sales Footprint
22.3.4.5. Strategy Overview
22.3.4.5.1. Marketing Strategy
22.3.4.5.2. Product Strategy
22.3.4.5.3. Channel Strategy
22.3.4.6. SWOT Analysis
22.3.5. Otsuka Pharmaceutical Factory Inc.
22.3.5.1. Product Portfolio
22.3.5.2. Product Claim
22.3.5.3. Revenue by Market Segments (Product /Channel /Region)
22.3.5.4. Sales Footprint
22.3.5.5. Strategy Overview
22.3.5.5.1. Marketing Strategy
22.3.5.5.2. Product Strategy
22.3.5.5.3. Channel Strategy
22.3.5.6. SWOT Analysis
22.3.6. Nestle (Nestle Health Science)
22.3.6.1. Product Portfolio
22.3.6.2. Product Claim
22.3.6.3. Revenue by Market Segments (Product /Channel /Region)
22.3.6.4. Sales Footprint
22.3.6.5. Strategy Overview
22.3.6.5.1. Marketing Strategy
22.3.6.5.2. Product Strategy
22.3.6.5.3. Channel Strategy
22.3.6.6. SWOT Analysis
22.3.7. Danone
22.3.7.1. Product Portfolio
22.3.7.2. Product Claim
22.3.7.3. Revenue by Market Segments (Product /Channel /Region)
22.3.7.4. Sales Footprint
22.3.7.5. Strategy Overview
22.3.7.5.1. Marketing Strategy
22.3.7.5.2. Product Strategy
22.3.7.5.3. Channel Strategy
22.3.7.6. SWOT Analysis
22.3.8. Meiji Holdings Co.
22.3.8.1. Product Portfolio
22.3.8.2. Product Claim
22.3.8.3. Revenue by Market Segments (Product /Channel /Region)
22.3.8.4. Sales Footprint
22.3.8.5. Strategy Overview
22.3.8.5.1. Marketing Strategy
22.3.8.5.2. Product Strategy
22.3.8.5.3. Channel Strategy
22.3.8.6. SWOT Analysis
22.3.9. Reckitt Benckiser Group Plc
22.3.9.1. Product Portfolio
22.3.9.2. Product Claim
22.3.9.3. Revenue by Market Segments (Product /Channel /Region)
22.3.9.4. Sales Footprint
22.3.9.5. Strategy Overview
22.3.9.5.1. Marketing Strategy
22.3.9.5.2. Product Strategy
22.3.9.5.3. Channel Strategy
22.3.9.6. SWOT Analysis
22.3.10. Fresenius Kabi
22.3.10.1. Product Portfolio
22.3.10.2. Product Claim
22.3.10.3. Revenue by Market Segments (Product /Channel /Region)
22.3.10.4. Sales Footprint
22.3.10.5. Strategy Overview
22.3.10.5.1. Marketing Strategy
22.3.10.5.2. Product Strategy
22.3.10.5.3. Channel Strategy
22.3.10.6. SWOT Analysis
22.3.11. B. Braun
22.3.11.1. Product Portfolio
22.3.11.2. Product Claim
22.3.11.3. Revenue by Market Segments (Product /Channel /Region)
22.3.11.4. Sales Footprint
22.3.11.5. Strategy Overview
22.3.11.5.1. Marketing Strategy
22.3.11.5.2. Product Strategy
22.3.11.5.3. Channel Strategy
22.3.11.6. SWOT Analysis
22.3.12. Victus
22.3.12.1. Product Portfolio
22.3.12.2. Product Claim
22.3.12.3. Revenue by Market Segments (Product /Channel /Region)
22.3.12.4. Sales Footprint
22.3.12.5. Strategy Overview
22.3.12.5.1. Marketing Strategy
22.3.12.5.2. Product Strategy
22.3.12.5.3. Channel Strategy
22.3.12.6. SWOT Analysis
22.3.13. Abbot Laboratories
22.3.13.1. Product Portfolio
22.3.13.2. Product Claim
22.3.13.3. Revenue by Market Segments (Product /Channel /Region)
22.3.13.4. Sales Footprint
22.3.13.5. Strategy Overview
22.3.13.5.1. Marketing Strategy
22.3.13.5.2. Product Strategy
22.3.13.5.3. Channel Strategy
22.3.13.6. SWOT Analysis
22.3.14. Fresenius SE & Co. KGaA
22.3.14.1. Product Portfolio
22.3.14.2. Product Claim
22.3.14.3. Revenue by Market Segments (Product /Channel /Region)
22.3.14.4. Sales Footprint
22.3.14.5. Strategy Overview
22.3.14.5.1. Marketing Strategy
22.3.14.5.2. Product Strategy
22.3.14.5.3. Channel Strategy
22.3.14.6. SWOT Analysis
22.3.15. Medtrition Inc
22.3.15.1. Product Portfolio
22.3.15.2. Product Claim
22.3.15.3. Revenue by Market Segments (Product /Channel /Region)
22.3.15.4. Sales Footprint
22.3.15.5. Strategy Overview
22.3.15.5.1. Marketing Strategy
22.3.15.5.2. Product Strategy
22.3.15.5.3. Channel Strategy
22.3.15.6. SWOT Analysis
22.3.16. Other Players (On Additional Requests)
22.3.16.1. Product Portfolio
22.3.16.2. Product Claim
22.3.16.3. Revenue by Market Segments (Product /Channel /Region)
22.3.16.4. Sales Footprint
22.3.16.5. Strategy Overview
22.3.16.5.1. Marketing Strategy
22.3.16.5.2. Product Strategy
22.3.16.5.3. Channel Strategy
22.3.16.6. SWOT Analysis
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Food and Beverage Insights
View Reports
Tube Feeding Formula Market
